Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib Maintenance in NDMM Post-ASCT
NCT02181413Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of ixazomib in multiple myeloma (MM), sponsored by Takeda. Started Jul 2014; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02181413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181413.